212

ALENDRONATE

Created:	2006-01-11
Last modified:	2021-03-01

Find Related PDB Entry
2 entries where 212 is found as a standalone ligand

Find related ligands: Help
Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	27
Chiral Atom Count	0
Bond Count	26
Aromatic Bond Count	0

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	ALENDRONATE
Synonyms	(4-AMINO-1-HYDROXY-1-PHOSPHONO-BUTYL)PHOSPHONIC ACID
Systematic Name (OpenEye OEToolkits)	(4-amino-1-hydroxy-1-phosphono-butyl)phosphonic acid
Formula	C₄ H₁₃ N O₇ P₂
Molecular Weight	249.096
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	O=P(O)(O)C(O)(CCCN)P(=O)(O)O
SMILES	CACTVS	3.341	NCCCC(O)([P](O)(O)=O)[P](O)(O)=O
SMILES	OpenEye OEToolkits	1.5.0	C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN
Canonical SMILES	CACTVS	3.341	NCCCC(O)([P](O)(O)=O)[P](O)(O)=O
Canonical SMILES	OpenEye OEToolkits	1.5.0	C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN
InChI	InChI	1.03	InChI=1S/C4H13NO7P2/c5-3-1-2-4(6,13(7,8)9)14(10,11)12/h6H,1-3,5H2,(H2,7,8,9)(H2,10,11,12)
InChIKey	InChI	1.03	OGSPWJRAVKPPFI-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB00630
Name	Alendronic acid
Description	Alendronic acid is a second generation bisphosphonate that is used for the treatment of some forms of osteoperosis and Paget's disease[FDA Label][A959,A203111]. It functions by preventing resorption of bone[FDA Label][A959].
Synonyms	Acido Alendronico Acide Alendronique Alendronate sodium 4-amino-1-hydroxybutane-1,1-diphosphonic acid (4-amino-1-hydroxybutylidene)bisphosphonic acid Alendronate Acidum Alendronicum Alendronate sodium anhydrous Alendronate calcium Alendronic acid ABDP (4-amino-1-hydroxybutane-1,1-diyl)bis(phosphonic acid)
Indication	Alendronic acid is indicated for the treatment and prevention of osteoporosis in men and postmenopausal women, treatment of glucocorticoid-induced osteoporosis, and Paget's disease of bone[FDA Label][A959,A176750]. However, alendronic acid is not indicated for use in pediatric populations or patients with a creatinine clearance <35mL/min[FDA Label].
Categories	Agents Causing Muscle Toxicity Bisphosphonates Bone Density Conservation Agents Drugs Affecting Bone Structure and Mineralization Drugs for Treatment of Bone Diseases Musculo-Skeletal System Organophosphonates Organophosphorus Compounds
ATC-Code	M05BB03 M05BA04 M05BB06 M05BB05
CAS number	66376-36-1

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

Name	Target Sequence	Pharmacological Action	Actions
Farnesyl pyrophosphate synthase	MPLSRWLRSVGVFLLPAPYWAPRERWLGSLRRPSLVHGYPVLAWHSARCW...	unknown	inhibitor
Hydroxylapatite	-	unknown	antagonist
Tyrosine-protein phosphatase non-receptor type 4	MTSRFRLPAGRTYNVRASELARDRQHTEVVCNILLLDNTVQAFKVNKHDQ...	unknown	inhibitor
Receptor-type tyrosine-protein phosphatase S	MAPTWGPGMVSVVGPMGLLVVLLVGGCAAEEPPRFIKEPKDQIGVSGGVA...	unknown	inhibitor
Receptor-type tyrosine-protein phosphatase epsilon	MEPLCPLLLVGFSLPLARALRGNETTADSNETTTTSGPPDPGASQPLLAW...	unknown	inhibitor
V-type proton ATPase catalytic subunit A	MDFSKLPKILDEDKESTFGYVHGVSGPVVTACDMAGAAMYELVRVGHSEL...	unknown	inhibitor
View More

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682